Combination therapy in hypertension (Q43702309)

26 November 2017

title

Combination therapy in hypertension. (English)

1 reference

26 November 2017

Alan H Gradman

1

1 reference

26 November 2017

Jan N Basile

2

1 reference

26 November 2017

Barry L Carter

3

1 reference

26 November 2017

George L Bakris

4

1 reference

26 November 2017

American Society of Hypertension Writing Group

5

1 reference

26 November 2017

publication date

10 December 2010

1 reference

Journal of Clinical Hypertension

26 November 2017

published in

1 reference

26 November 2017

volume

13

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

146-154

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Insufficient control of blood pressure and incident diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Evolving strategies for the use of combination therapy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Fixed-dose combinations improve medication compliance: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Renin inhibition in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Captopril and hydrochlorothiazide: rationale for their combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Atenolol in hypertension: is it a wise choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Atenolol and chlorthalidone in combination for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Diuretic therapy for hypertension and the risk of primary cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Resistant or difficult-to-treat hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Hydrochlorothiazide with or without amiloride for hypertension in the elderly. A dose-titration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Predictors of hyperkalemia risk following hypertension control with aldosterone blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00397.X

10.1111/J.1751-7176.2010.00397.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference